Evaluation of Safety and Immunogenicity of Combined Immunization of PPV23 and IIV4

NCT04559204 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

1224

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza, Human
Pneumonia, Pneumococcal

Interventions

BIOLOGICAL: IIV4 and PPV23
BIOLOGICAL: IIV4
BIOLOGICAL: PPV23

Sponsor

China National Biotec Group Company Limited

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]